A smiling woman on the beach looking towards the sky. Image is in the shape of a droplet.

Refreshing Lives

One Patient at a Time

What Makes Us Different

We understand that our patients are in challenging situations.
That is why we take the utmost care in providing a safe, calming, spa-like facility that emanates positivity.
A young African-American girl smiling and looking refreshed on the beach.

We Accept Most Major Insurances

Cigna Logo
Florida Blue Logo
Humuna military Logo
lifestance health Logo
value options Logo
united healthcare Logo
MHNet behavioral health Logo
humuna Logo
Aetna Logo
magellan health Logo
tricare Logo
sunshine health Logo
avmed embrace better health Logo
Concordia university Logo
Elderly couple walking on the beach with their arms behind each others backs.

What We Believe

Our mission is to cultivate psychological well-being through empathetic, patient-centered approaches to care.




What We Offer

Spravato (esKetamine)

  • Spravato is the brand name for esketamine, an FDA-approved medication since March 2019 for the treatment of treatment-resistant depression (TRD) and Major Depression with suicidal ideation in adults. Treatment-resistant depression is characterized by a lack of adequate response to at least two different antidepressant treatments.
  • For adults experiencing Major Depressive Disorder (MDD) who have attempted two or more antidepressants without success, Spravato presents itself as a viable option. Administered via nasal spray, it is meant to complement oral antidepressant therapy.
Spravato works differently than other medications for treatment- resistant depression

  • Contemporary oral antidepressants are widely understood to alleviate depression by elevating neurotransmitter levels in specific brain regions that influence mood. In contrast, Spravato focuses on the N-Methyl-D-Aspartate (NMDA) receptor, representing a departure from the mechanisms of action seen in currently prescribed oral antidepressants.
  • Esketamine, being the enantiomer of ketamine and an NMDA antagonist, operates by augmenting levels of the neurotransmitter glutamate and a growth factor known as BNDF.
Treatment Plan: The treatment plan typically involves an induction phase, where patients receive the nasal spray twice a week for 4 weeks, and a maintenance phase, where the frequency may be reduced.

  • Spravato is not a pain reliever or an aesthetic.
  • Side effects include dissociation, dizziness, nausea, sleepiness, feeling anxious, lack of energy, feeling very happy or excited. See the Spravato medication guide for complete safety information.
Risk Evaluation and Mitigation Strategy (REMS): Because of the potential for abuse and serious adverse outcomes, Spravato is only available through a restricted distribution system under a REMS program. Its use is closely monitored by healthcare professionals to maintain safety protocol.


Come in and relax in our chair

The spray is administered in your nasal cavity

Relax while our team supervises

Make sure to have someone drive you home!

TMS Therapy

Refresh TMS uses NeuroStar® Advanced Therapy, which is a patented TMS technology that utilizes a magnetic coil to stimulate regions of the brain associated with depression symptoms.
Doctor Paula Ann Francis, M.D.

Get started today with

Paula-Ann Francis, M.D.

2022 Best of Weston: Best Psychiatrist